US 12,085,574 B2
Method and means for diagnosing and treating allergy
Franziska Roth-Walter, Vienna (AT); Erika Jensen-Jarolim, Vienna (AT); Cristina Gomez-Casado, Getafe (ES); Araceli Diaz Perales, Madrid (ES); Luis Fernandez Pacios, Madrid (ES); and Josef Singer, Kleinbaumgarten (AT)
Assigned to BIOMEDICAL INTERNATIONAL R+D GMBH, Vienna (AT)
Filed by BIOMEDICAL INTERNATIONAL R+D GMBH, Vienna (AT)
Filed on Jan. 13, 2021, as Appl. No. 17/147,699.
Application 17/147,699 is a continuation of application No. 15/111,162, granted, now 10,914,744, previously published as PCT/EP2015/050126, filed on Jan. 7, 2015.
Claims priority of application No. 14150965 (EP), filed on Jan. 13, 2014.
Prior Publication US 2021/0208164 A1, Jul. 8, 2021
Int. Cl. A61K 39/35 (2006.01); A61K 31/295 (2006.01); A61K 31/315 (2006.01); A61K 31/353 (2006.01); A61K 39/00 (2006.01); A61K 47/55 (2017.01); C07K 14/47 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01)
CPC G01N 33/6893 (2013.01) [A61K 31/295 (2013.01); A61K 31/315 (2013.01); A61K 31/353 (2013.01); A61K 39/35 (2013.01); A61K 47/551 (2017.08); C07K 14/47 (2013.01); G01N 33/6863 (2013.01); G01N 33/92 (2013.01); A61K 39/00 (2013.01); G01N 2800/24 (2013.01)] 10 Claims
 
1. A method for treating allergies, which comprises administering to a patient in need thereof, a therapeutically effective amount of at least one protein selected from human lipocalin 2, Aln g 1, Alt a 1, Art v 1, Bet v 1, BLG, Bos d 5, Can f 1, Can f 2, Can f 6, Cor a 1, Dau c 1 Equ c 1, Equ c 2, Fag s 1 Fra a 1, Fel d 4, Fel d 7, Gly m 4, Mal d 1, Mus m 1, Ole e 1, Que a 1, Rat n 1, Rub 1 1, and Sus s 1; wherein the protein is provided in its holo-form.